Adult Vaccines Global Market Report 2025

Description

Adult vaccines are immunizations administered to adults to stimulate an immune response against disease-causing pathogens. These vaccines play a crucial role in the prevention and treatment of various diseases affecting adults, including influenza, pneumococcal disease, and herpes.

The primary types of adult vaccines include monovalent and multivalent options. A monovalent vaccine contains the mRNA component of a single virus, triggering an immune response against a specific antigen. Various technologies are employed in the development of adult vaccines, including live attenuated vaccines, inactivated viral or bacterial vaccines, toxoid vaccines, recombinant vaccines, and conjugate vaccines. These vaccines find applications in preventing diseases such as influenza, diphtheria, pertussis, tetanus (dPT), human papillomavirus, shingles (zoster), pneumococcal disease, and hepatitis. Healthcare firms and hospitals are key users of these vaccines.

The adult vaccines market research report is one of a series of new reports from The Business Research Company that provides adult vaccines market statistics, including adult vaccines industry global market size, regional shares, competitors with a adult vaccines market share, detailed adult vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the adult vaccines industry. This adult vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adult vaccines market size has grown strongly in recent years. It will grow from $22.82 billion in 2024 to $24.49 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing aging population, government vaccination programs, growing awareness of preventive healthcare, vaccine development and innovation, public health campaigns.

The adult vaccines market size is expected to see strong growth in the next few years. It will grow to $35.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to emergence of new infectious threats, increasing focus on immunization registries, rising threat of antimicrobial resistance, global efforts for pandemic preparedness, shift toward personalized vaccines, increased focus on maternal immunization. Major trends in the forecast period include digital health integration, technological advancements in vaccine production, collaborations between governments and pharmaceutical companies, advancements in vaccine delivery technologies, expanding immunization programs.

The rising incidence of contagious diseases is propelling the adult vaccine market forward. Contagious diseases are those that can be transmitted from one person to another. Vaccines enable individuals to develop immunity against these diseases, making them a highly effective means of combating infections. For example, in March 2023, the Centers for Disease Control and Prevention, a national public health agency based in the United States, reported that in 2022, there were 8,300 cases of tuberculosis in the country, an increase from 7,874 cases in 2021. The incidence of TB in 2022 rose slightly to 2.5 per 100,000 individuals, compared to 2.4 in 2021. Therefore, the increasing prevalence of contagious diseases is driving the growth of the adult vaccine market.

The rise in healthcare expenditure has bolstered the growth of the adult vaccine market. Healthcare expenditure refers to the overall costs associated with healthcare services provided to a population. An increase in healthcare spending often results in more funding for medical research and development. By investing in vaccination programs and enhancing access to vaccines, healthcare systems can alleviate the burden of preventable diseases and improve the overall health of the population. Moreover, adult vaccination can lead to substantial cost savings by decreasing healthcare utilization and the necessity for expensive treatments. For example, in November 2023, the Canadian Institute for Health Information, a health organization based in Canada, projected that Canada's total health expenditure in 2023 would reach $344 billion, representing an increase of over $9 billion compared to 2022. Therefore, the rise in healthcare expenditure has positively influenced the growth of the adult vaccine market.

Product innovation emerges as a pivotal trend driving the evolution of the adult vaccines market. Major industry players are introducing innovative products to fortify their market presence. For instance, in August 2022, GSK, a UK-based biopharma company, partnered with IQVIA, an India-based global provider of advanced analytics and clinical research services, to launch Vaccine Track. This pioneering data trend platform aims to enhance adult vaccination efforts nationwide by providing real-time, pertinent data trends that focus on improving public health initiatives. The advent of such innovative tools underscores the industry's commitment to leveraging data and technology to advance adult vaccination strategies and address prevailing healthcare challenges.

Prominent players within the adult vaccine market are emphasizing strategic collaborations aimed at the development and commercialization of personalized cancer vaccines. These collaborations, centered on mutual objectives, are pivotal business relationships between multiple companies. For instance, in October 2022, Merck & Co., Inc., an American multinational pharmaceutical company, partnered with Moderna, a US-based pharmaceutical and biotechnology company, to collectively advance and commercialize the personalized cancer vaccine mRNA-4157/V940. Under their existing collaboration and license agreement, both entities will collaborate on the development and commercialization of mRNA-4157/V940, which is currently undergoing assessment in a Phase 2 clinical trial conducted by Moderna. This vaccine is being evaluated alongside KEYTRUDA, Merck's anti-PD-1 therapy, as an adjuvant treatment for high-risk melanoma patients.

In August 2022, GSK, a UK-based pharmaceutical giant, acquired Affinivax, Inc., a US-based clinical-stage biopharmaceutical company, in a deal of undisclosed value. This strategic acquisition aligns with GSK's broader strategy of bolstering its portfolio in specialty medicines and vaccines, particularly focusing on innovative vaccine candidates for pneumococcal disease. Affinivax, Inc., known for its pioneering work in next-generation pneumococcal vaccines and adult vaccines based on the Multiple Antigen Presenting System (MAPS) platform technology, is expected to complement GSK's efforts in advancing cutting-edge vaccine solutions. This strategic move underscores GSK's commitment to driving advancements in adult vaccines and strengthening its position within the healthcare landscape.

Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adult vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The adult vaccines market consists of sales of mRNA vaccines and viral vector vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adult Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adult vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adult vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adult vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Vaccine Type: Monovalent; Multivalent
2) By Technology: Live Attenuated Vaccines; Inactivated Viral Or Bacterial Vaccines; Toxoid Vaccines; Recombinant Vaccines; Conjugate Vaccines
3) By Application: Influenza; DPT; Human Papillomavirus; Zoster; Pneumococcal; Hepatitis
4) By End Users: Healthcare Firms; Hospitals
Subsegments:
1) By Monovalent: Single Antigen Vaccines; Specific Disease Vaccines
2) By Multivalent: Combination Vaccines; Multi-Antigen Vaccines
Companies Mentioned: GlaxoSmithKline PLC; Merck & Co; Sanofi Pasteur; Pfizer Inc; Commonwealth Serum Laboratories Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23106

1. Executive Summary

2. Adult Vaccines Market Characteristics

3. Adult Vaccines Market Trends And Strategies

4. Adult Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Adult Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Adult Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Adult Vaccines Market Growth Rate Analysis
5.4. Global Adult Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Adult Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Adult Vaccines Total Addressable Market (TAM)

6. Adult Vaccines Market Segmentation

6.1. Global Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monovalent
Multivalent
6.2. Global Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Attenuated Vaccines
Inactivated Viral or Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
6.3. Global Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Influenza
DPT
Human Papillomavirus
Zoster
Pneumococcal
Hepatitis
6.4. Global Adult Vaccines Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Healthcare Firms
Hospitals
6.5. Global Adult Vaccines Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Antigen Vaccines
Specific Disease Vaccines
6.6. Global Adult Vaccines Market, Sub-Segmentation Of Multivalent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Combination Vaccines
Multi-Antigen Vaccines

7. Adult Vaccines Market Regional And Country Analysis

7.1. Global Adult Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Adult Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Adult Vaccines Market

8.1. Asia-Pacific Adult Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Adult Vaccines Market

9.1. China Adult Vaccines Market Overview
9.2. China Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Adult Vaccines Market

10.1. India Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Adult Vaccines Market

11.1. Japan Adult Vaccines Market Overview
11.2. Japan Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Adult Vaccines Market

12.1. Australia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Adult Vaccines Market

13.1. Indonesia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Adult Vaccines Market

14.1. South Korea Adult Vaccines Market Overview
14.2. South Korea Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Adult Vaccines Market

15.1. Western Europe Adult Vaccines Market Overview
15.2. Western Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Adult Vaccines Market

16.1. UK Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Adult Vaccines Market

17.1. Germany Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Adult Vaccines Market

18.1. France Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Adult Vaccines Market

19.1. Italy Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Adult Vaccines Market

20.1. Spain Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adult Vaccines Market

21.1. Eastern Europe Adult Vaccines Market Overview
21.2. Eastern Europe Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Adult Vaccines Market

22.1. Russia Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Adult Vaccines Market

23.1. North America Adult Vaccines Market Overview
23.2. North America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Adult Vaccines Market

24.1. USA Adult Vaccines Market Overview
24.2. USA Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Adult Vaccines Market

25.1. Canada Adult Vaccines Market Overview
25.2. Canada Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Adult Vaccines Market

26.1. South America Adult Vaccines Market Overview
26.2. South America Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Adult Vaccines Market

27.1. Brazil Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Adult Vaccines Market

28.1. Middle East Adult Vaccines Market Overview
28.2. Middle East Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Adult Vaccines Market

29.1. Africa Adult Vaccines Market Overview
29.2. Africa Adult Vaccines Market, Segmentation By Vaccine, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Adult Vaccines Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Adult Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Adult Vaccines Market Competitive Landscape And Company Profiles

30.1. Adult Vaccines Market Competitive Landscape
30.2. Adult Vaccines Market Company Profiles
- 30.2.1. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Commonwealth Serum Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis

31. Adult Vaccines Market Other Major And Innovative Companies

31.1. Johnson & Johnson
31.2. Serum Institute of India
31.3. AstraZeneca PLC
31.4. Novartis AG
31.5. Protein Sciences Corporation
31.6. Emergent BioSolutions Inc.
31.7. Bavarian Nordic A/S
31.8. Dynavax Technologies Corporation
31.9. Novavax Inc
31.10. Medimmune LLC
31.11. BioNTech SE
31.12. Moderna
31.13. Inovio Pharmaceuticals
31.14. Sinovac
31.15. Valneva Se

32. Global Adult Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adult Vaccines Market

34. Recent Developments In The Adult Vaccines Market

35. Adult Vaccines Market High Potential Countries, Segments and Strategies

35.1 Adult Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Adult Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Adult Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer